DIAGNOSING DISEASES

Brand	Owner (click to sort)	Address	Description
EXPLORER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
INSPECTOR	Protana A/S	Staermosegardsvej 16 Odense M Denmark	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
MAPPER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
NANOES	Protana A/S	Staermosegardsvej 16 Odense M Denmark	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
PATHMAP EXPLORER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;

PATHMAP MAPPER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
PATHMAP PROFILER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
PATHMAP TARGETER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
PEPSEA	Protana A/S	Staermosegardsvej 16 Odense M Denmark	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
PROFILER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
PROTANA	Protana A/S	Staermosegardsvej 16 Odense M Denmark	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
PROTEOMEDB	Protana A/S	Staermosegardsvej 16 Odense M Denmark	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
SOFTSPOT	Protana A/S	Staermosegardsvej 16 Odense M Denmark	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
TARGETER	MDS Proteomics Inc.	251 Attwell Drive Toronto Ontario M9W 7H4 Canada	Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer.